Showing results (221-230 of 541) with videos related to

Sort By:
Pageof 55
Drugs - Real World Outcomes|June 24, 2018
Real-World Adverse Effects of Capecitabine Toxicity in an Elderly PopulationMichiel W H van Beek, Monique Roukens, Wilco C H Jacobs, et al.
Drugs - Real World Outcomes|June 28, 2020
Clinical Outcomes and Economic Impact of Oritavancin for Gram-Positive Infections: A Single Academic Medical Center Health System ExperienceLauren E Brownell, Meagan L Adamsick, Erin K McCreary, et al.
Drugs - Real World Outcomes|June 27, 2020
A Two-Dose Oritavancin Regimen Using Pharmacokinetic Estimation AnalysisWarren E Rose, Paul R Hutson
Drugs - Real World Outcomes|June 27, 2020
Real-World Use of Oritavancin for the Treatment of OsteomyelitisPatrick J Scoble, Joseph Reilly, Glenn S Tillotson
Drugs - Real World Outcomes|May 23, 2023
Assessment of Codispensing Patterns of Mirabegron and Prespecified CYP2D6 Substrates in Patients with Overactive BladderJingjun Wang, Mary E Ritchey, Kamika Reynolds, et al.
Drugs - Real World Outcomes|August 6, 2022
Rituximab and Pyoderma Gangrenosum: An Investigation of Disproportionality Using a Systems Biology-Informed Approach in the FAERS DatabaseJodie Belinda Hillen, Ty Stanford, Michael Ward, et al.
Drugs - Real World Outcomes|May 27, 2020
Knowledge and Understanding of the Safety and Efficacy Aspects of BRIDION® Among Canadian AnesthesiologistsAnnette Stemhagen, Parambir Bhangu, Wenjun Zhong, et al.
Drugs - Real World Outcomes|June 14, 2020
Using Real-World Data to Predict Clinical and Economic Benefits of a Future Drug Based on its Target Product ProfileChristoph Gerlinger, Thomas Evers, Jeremy Rassen, et al.
Drugs - Real World Outcomes|February 1, 2023
Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the NetherlandsAnnemarie Voss, Elisabeth Smits, Karin M A Swart, et al.
Pageof 55